CAJ | 학술논문

就近期美国联邦最高法院Mayo v．Prometheus案的判决，对美国《专利法》第101条“专利适格标的”产生的影响进行了研究。对Mayo基本案情进行介绍后，梳理了近年来美国《专利法》第101条专利适格标的范围及其检测标准的变化，指出美国专利标的物范围一直缺乏清晰、明确的界定；专利适格标的检测方法虽历经多次变革，但始终无法形成一个统一、清晰的检测标准。从法律功能、专利效力、产业发展等角度，分析了Mayo案件判决产生的影响，并就企业创新成果的保护、专利中请提出了建议。
취근기미국련방최고법원Mayo v．Prometheus안적판결，대미국《전리법》제101조“전리괄격표적”산생적영향진행료연구。대Mayo기본안정진행개소후，소리료근년래미국《전리법》제101조전리괄격표적범위급기검측표준적변화，지출미국전리표적물범위일직결핍청석、명학적계정；전리괄격표적검측방법수력경다차변혁，단시종무법형성일개통일、청석적검측표준。종법률공능、전리효력、산업발전등각도，분석료Mayo안건판결산생적영향，병취기업창신성과적보호、전리중청제출료건의。
This article provides analysis and insight on the U.S. Supreme Court＇s recent ruling in Mayo v. Prometheus involving patent eligibility of methods in the area of personalized medicine. A review of the recent doctrinal development is conducted after the Mayo case＇s introduction. The study shows that the standard of patentable subject matter under 35 U.S.C 101 suffers from a lack of clarity. Then, the article analyzes how Mayo v. Prometheus may affect the existing patents, the examination and decision implemented by the USPTO, and the developing of the life science area. Finally, some strategies and practices are provided to help the inventors to protect innovation in light of the Mayo＇s decision.